In January 2023, a significant acquisition occurred as Verinata Health, Inc. was purchased for $1.9 billion. The market for preterm birth diagnostic kits features key players like Qiagen and Hologic Inc., with products including ffN and PAMG-1 tests, serving hospitals and diagnostic labs across various global regions. The preterm birth prevention market is projected to grow from $1.70 billion in 2024 to over $4.49 billion by 2034, reflecting a robust CAGR of 10.2%.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.